Literature DB >> 10435137

Bilateral synchronous tonsillar carcinoma.

D Rajenderkumar1, K K Chan, K A Hayward, R D McRae.   

Abstract

Synchronous cancers occur in four per cent of patients with head and neck malignancies but no bilateral synchronous tonsillar carcinomas have been described in the English literature. We describe the first such case and discuss the prognostic aspect of this carcinoma. In the presence of contralateral neck nodes in patients with head and neck malignancies, a careful search should be made for a second head and neck primary.

Entities:  

Mesh:

Year:  1999        PMID: 10435137     DOI: 10.1017/s0022215100143713

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

1.  Can diffusion-weighted imaging distinguish between normal and squamous cell carcinoma of the palatine tonsil?

Authors:  K S S Bhatia; A D King; D K W Yeung; F Mo; A C Vlantis; K-H Yu; J K T Wong; A T Ahuja
Journal:  Br J Radiol       Date:  2010-07-20       Impact factor: 3.039

2.  Severe prolonged dysphagia following transoral resection of bilateral synchronous tonsillar carcinoma.

Authors:  Alpen B Patel; Michael L Hinni; Taylor R Pollei; Richard E Hayden; Eric J Moore
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-08       Impact factor: 2.503

Review 3.  Bilateral synchronous tonsillar carcinoma: a case series and review of the literature.

Authors:  Daniel Moualed; A Qayyum; T Price; A Sharma; S Mahendran
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-04-03       Impact factor: 2.503

4.  Bilateral synchronous tonsillar carcinoma in cervical cancer of unknown primary site (CUPS).

Authors:  Ilkay Kazak; Andreas Haisch; Sergije Jovanovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-09       Impact factor: 2.503

Review 5.  Synchronous bilateral tonsil carcinoma: case presentation and review of the literature.

Authors:  M-N Theodoraki; J A Veit; T K Hoffmann; J Greve
Journal:  Infect Agent Cancer       Date:  2017-06-26       Impact factor: 2.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.